We are live on
!
Find out more
PCM
Penserra Capital Management Portfolio holdings
AUM
$8.52B
1-Year Est. Return
37.76%
This Fund
S&P 500
This Quarter
Est. Return
-6.54%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.21B
AUM Growth
-$467M
(-10%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
1,530
New
187
Increased
504
Reduced
693
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$46.1M |
| 2 |
Aflac
AFL
|
+$37.1M |
| 3 |
United Parcel Service
UPS
|
+$34.9M |
| 4 |
Intercontinental Exchange
ICE
|
+$31.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$43M |
| 2 |
Honeywell
HON
|
+$38M |
| 3 |
Caterpillar
CAT
|
+$37.4M |
| 4 |
Walmart Inc
WMT
|
+$27.6M |
| 5 |
Newmont
NEM
|
+$22.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.42% |
| 2 | Consumer Discretionary | 15.84% |
| 3 | Financials | 9.48% |
| 4 | Communication Services | 9.36% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Beam Therapeutics
BEAM
$2.82B
| $97K | ﹤0.01% |
+1,700
| New | +$112K |
|
|
DOCU
852
DocuSign
DOCU
$11.4B
| $97K | ﹤0.01% |
910
+54
| +6% | +$6.2K |
|
853
Intellia Therapeutics
NTLA
$1.68B
| $97K | ﹤0.01% |
+1,348
| New | +$114K |
|
|
CPUH
854
DELISTED
Compute Health Acquisition Corp.
CPUH
| $97K | ﹤0.01% |
9,933
-7,249
| -42% | -$70.7K |
|
855
Dynatrace
DT
$14.6B
| $96K | ﹤0.01% |
2,046
+682
| +50% | +$32.1K |
|
856
TransUnion
TRU
$15.2B
| $96K | ﹤0.01% |
930
+81
| +10% | +$8.22K |
|
857
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.22B
| $96K | ﹤0.01% |
+1,376
| New | +$99.7K |
|
858
Corpay
CPAY
$26.2B
| $95K | ﹤0.01% |
383
+23
| +6% | +$5.45K |
|
|
VIP
859
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$29.9M
| $93K | ﹤0.01% |
+1,090
| New | +$121K |
|
860
Liberty Broadband Class C
LBRDK
$5.18B
| $93K | ﹤0.01% |
688
+42
| +7% | +$6.12K |
|
861
System1
SST
$17.8M
| $93K | ﹤0.01% |
645
-471
| -42% | -$57.8K |
|
862
Thermo Fisher Scientific
TMO
$222B
| $93K | ﹤0.01% |
160
+94
| +142% | +$54K |
|
863
Markel Group
MKL
$22.8B
| $92K | ﹤0.01% |
63
+5
| +9% | +$6.46K |
|
864
Molina Healthcare
MOH
$10.4B
| $92K | ﹤0.01% |
278
+20
| +8% | +$6.16K |
|
865
Zscaler
ZS
$28.6B
| $92K | ﹤0.01% |
382
+23
| +6% | +$5.65K |
|
|
CONX
866
DELISTED
CONX Corp. Class A Common Stock
CONX
| $92K | ﹤0.01% |
9,360
-6,833
| -42% | -$67.1K |
|
867
Boston Properties
BXP
$10.8B
| $91K | ﹤0.01% |
709
+71
| +11% | +$8.6K |
|
868
Palantir
PLTR
$421B
| $91K | ﹤0.01% |
6,696
+2,232
| +50% | +$29.8K |
|
|
WBX
869
Wallbox
WBX
$79.6M
| $91K | ﹤0.01% |
360
-96
| -21% | -$25.5K |
|
|
TLMD
870
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
| $91K | ﹤0.01% |
30,602
+15,529
| +103% | +$34.2K |
|
871
BRC Inc
BRCC
$216M
| $90K | ﹤0.01% |
+4,356
| New | +$76.9K |
|
|
CANG
872
Cango Inc
CANG
$67.7M
| $90K | ﹤0.01% |
+3,478
| New | +$108K |
|
873
GlobalFoundries
GFS
$27.5B
| $90K | ﹤0.01% |
+1,449
| New | +$85.5K |
|
874
Synchrony
SYF
$25.4B
| $90K | ﹤0.01% |
2,588
+144
| +6% | +$6.03K |
|
875
Waters Corp
WAT
$40.4B
| $90K | ﹤0.01% |
291
+19
| +7% | +$6.18K |
|
Similar funds
GRQ
IC
NB
DM
ACM
FT
AAF
MC
Penserra Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Penserra Capital Management held 1,530 positions worth $4.21B, down 10% from $4.68B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Penserra Capital Management's Q1 2022 filing shows 187 new, 504 increased, 693 reduced and 84 closed positions. Its largest new stake was Merck: 316,583 shares worth $26M. The largest sale was Xilinx Inc, an estimated $43M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Financials.
- Penserra Capital Management's largest Q1 2022 buy was Merck: 316,583 shares worth $26M.
- Penserra Capital Management added most to Deere & Co in Q1 2022, an estimated $46.1M increase.
- Penserra Capital Management's biggest Q1 2022 reduction was Honeywell, cutting an estimated $38M.
- Penserra Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $43M.
- Penserra Capital Management's ten largest holdings make up 17% of its $4.21B portfolio in Q1 2022.
- Penserra Capital Management opened 187 new positions and closed 84 in Q1 2022.
- Penserra Capital Management's portfolio value fell 10% quarter-over-quarter to $4.21B.
Based on Penserra Capital Management's 13F filing for Q1 2022, filed 13 May 2022.